Global Pharmaceutical Company
Ardmac were approved to construct a new high containment, state of the art production facility dedicated to the manufacture of oncology product Ninlaro, a treatment for patients with multiple myeloma, a condition affecting blood plasma, for global markets. The purpose of this project was to deliver a new, high containment, all-in-one building for the production, packaging and warehousing of Ninlaro. The building is located on part of the existing client location in Dublin.
Ardmac provided architectural cleanroom package finishes for the project, which was procured as a performance envelope of cleanroom manufacturing space and QC clean lab area. Ninlaro is different from other proteasome inhibitor medicines as it is the first and only oral medication of its kind and it can be taken at home.
With the introduction of next generation cleanroom products, Ardmac designed a clash free 1600m2 cleanroom using the latest 3D modelling BIM technology and Last Planner successfully. The use of our innovative Twin Cassette ceiling created a flexible interchangeable modular ceiling with a multi directional concealed cable management system. This 2.5Kn/M2 ceiling also created a platform that facilitated dual construction which contributed greatly to completing this fast track project on time.
The facility featured a 12-metre high API clean area enclosing a structural platform and with the introduction of multiple glazed partition it allows natural light to penetrate the cleanroom. The integration of flush doors and windows, epoxy floors with covered flush skirtings, Pharma seal terminal HEPA housings, integrated return air columns and safe change units, Decontaminating misting showers and product transfer hatches all contributed to providing the fully GMP compliant facility.
The cleanroom construction commenced in Jan 2018 as per agreed schedule and was handed over on time in July 2018 to facilitate production processes starting thereafter.
Client: Global Pharma Company
Duration: 6 months